Amyotrophic lateral sclerosis has been a tough area for drug research, but Eli Lilly has been spreading its bets in this neurodegenerative disease by striking deals with other companies.

Persist AI announced a $12 million Series A funding round to support its new Cloud Lab platform, allowing companies to use its lab remotely for research and development.

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing its first drug asset from ... Alchemab, an AI and machine learning ...

As AI continues to permeate the drug development pathway, major players like Eli Lilly, Sanofi, and BioNTech have ...

INDIANAPOLIS — Over the next eight years, Eli Lilly and Company and Purdue ... including: Applying AI-powered tools to augment traditional drug discovery methods while leveraging advancements ...

We recently published an article titled Jim Cramer Says AI Is Back ... that the weight loss drug market is now dependent on a pill, and his latest comments about Eli Lilly and Company (NYSE ...

INDIANAPOLIS — Indianapolis-based pharmaceutical giant Eli Lilly and Company ... Purdue and Lilly said they will concentrate on these areas as part of the partnership: Applying AI-powered tools to ...

Once the AI models predict a set of formulations, Persist's Cloud Lab enables pharmaceutical scientists to test the formulation by remotely controlling the robotic lab. With a combination of ...

Pharmaceutical giant Eli Lilly ... Lilly CEO David Ricks says artificial intelligence is critical to the future. “There’s a strong focus on using AI-powered tools to drive drug discovery.

Isomorphic's technology platform has already generated a number of AI models that are being applied to the discovery of new medicines, and it already counts Eli ... AI drug design engine, help ...

Shares of Eli Lilly (LLY) and other pharmaceutical firms fell on a report President Trump will move to slash Medicare drug prices. Oil futures gained. Gold prices dropped. The yield on the 10-year ...